Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients

Wen Zhang(Xidian University), Aiping Zhou(National Cancer Center)
Clinical Cancer Research
March 11, 2022
Cited by 56


Related Papers